Organon Pharma Indonesia PT (ISX:SCPI) Debt-to-Equity : 0.00 (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Debt-to-Equity?

Organon Pharma Indonesia PT's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil. Organon Pharma Indonesia PT's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was Rp0.00 Mil. Organon Pharma Indonesia PT's Total Stockholders Equity for the quarter that ended in . 20 was Rp0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Organon Pharma Indonesia PT's Debt-to-Equity or its related term are showing as below:

ISX:SCPI's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Organon Pharma Indonesia PT Debt-to-Equity Historical Data

The historical data trend for Organon Pharma Indonesia PT's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Debt-to-Equity Chart

Organon Pharma Indonesia PT Annual Data

Trend

Debt-to-Equity

Organon Pharma Indonesia PT Quarterly Data

Debt-to-Equity

Competitive Comparison of Organon Pharma Indonesia PT's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Organon Pharma Indonesia PT's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's Debt-to-Equity falls into.

Organon Pharma Indonesia PT Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Organon Pharma Indonesia PT's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/	N/A
	=	N/A

Organon Pharma Indonesia PT's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(	+	)	/
	=	N/A

Organon Pharma Indonesia PT (ISX:SCPI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Organon Pharma Indonesia PT Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920

Website

https://www.organon.com/indonesia

Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines